Sponsors and Exhibitors
These sponsors and supporters make the ESB 2021 Conference possible:
As the most recent strategic segment within Rousselot, we have drawn upon Rousselot’s 125+ years of worldwide expertise and proven track record of pharmaceutical gelatins and collagens to develop X-Pure®, an innovative range of purified gelatins and collagens specifically designed for (bio)medical applications. Offering unique advantages to assure performance, quality and safety, X-Pure is backed by strong scientific data and on-going research. Rousselot Biomedical is committed to facilitating the use of X-Pure in your applications and to help “Advancing medical science”.
Lunch Symposium Rousselot: Biomedical Applications of Gelatins
Tuesday, Sept 07, 2021
1:30 p.m. – 2:15 p.m.
Speakers and Chairs
University of Twente, Enschede, NL
Rousselot, Gent, BE
Rousselot introduction – Jeff Daelman
Biomedical applications for Gelatins – Jeroen Leijten
Modified gelatins: from bench to patient – Jeff Daelman
Q&A – Jeff Daelman
Biomaterials is an international journal covering the science and clinical application of biomaterials. It is the aim of the journal to provide a peer-reviewed forum for the publication of original papers and authoritative review and opinion papers dealing with the most important issues facing the use of biomaterials in clinical practice. The scope of the journal covers the wide range of physical, biological and chemical sciences that underpin the design of biomaterials and the clinical disciplines in which they are used. These sciences include polymer synthesis and characterization, drug and gene vector design, the biology of the host response, immunology and toxicology and self assembly at the nanoscale. Clinical applications include the therapies of medical technology and regenerative medicine in all clinical disciplines, and diagnostic systems that reply on innovative contrast and sensing agents. The journal is relevant to areas such as cancer diagnosis and therapy, implantable devices, drug delivery systems, gene vectors, bionanotechnology and tissue engineering.
Biomaterials Science is the official journal of the European Society of Biomaterials. Published on a not-for-profit basis by the Royal Society of Chemistry, the journal presents high impact work focused on exploring the design, function, and interactions of biomaterials. Its scope encompasses new concepts in biomaterials design, studies into the interaction of biomaterials with the body, and the use of materials to answer fundamental biological questions. The journal is led by Editor-in-Chief Jianjun Cheng, alongside an international Editorial Board of expert Associate Editors.
Enzifarma S.A. is a leading Portuguese company operating in niche healthcare segments, namely in the import and commercialization of state-of-the-art solutions for the laboratory area, considered a PME Líder ’20 with Quality Control in compliance with ISO 9001:2015. Founded in 1996, with headquarters in Lisbon and warehouse operation in the Porto region, where there is also an office that offers administrative support in the commercialization, storage and dispatch processes.
We consider our mission to know how to be rigorous and efficient with us and our suppliers, as a way to achieve and maintain a leadership position in the quality of the products and services provided, for a better satisfaction of our customers, shareholders, society and all interested parties, namely the companies we represent. Thus, we strive to understand, satisfy and anticipate customers‘ needs, building with them a strong and stable relationship. In organizational terms, the company operates according to a business area strategy, and a cross-logic of marketing and product applicability (technical-scientific).
PRODUCTS & EQUIPMENT
Genomics, Cell Biology, Cell Growth and Differentiation and Drug Discovery. We work with leading brands as well as innovative emerging brands, with guaranteed quality and guarantee that drive technological advances in life science research. We offer a wide range of techniques, tools and solutions in the areas of genomics, cell biology, cell growth and differentiation as well as in the development of new drugs.
FLUIDINOVA is a specialized manufacturer of synthetic nano-hydroxyapatite and tricalcium phosphate materials marketed as nanoXIM®. FLUIDINOVA provides companies and research institutions around the world with unique and high quality calcium phosphates for the development of medical devices, oral care cosmetics and food products. Particularly, for medical applications, our products are successfully used as bone graft substitutes with improved regenerative performance. Our focus on customer satisfaction and innovation helps us to establish close relationships with clients to develop the best solutions to incorporate our materials in their final products to address a vast number of applications.
Ceramics (ISSN 2571-6131) is an international peer-reviewed open access journal of ceramics science and engineering published quarterly online by MDPI. It is indexed within Emerging Sources Citation Index (Web of Science), and other relevant databases. It provides a forum for publishing papers which advance the in-depth understanding of the relationship between the structure, the microstructure, the properties and the applications of ceramic materials. It publishes reviews, regular research papers (articles) and short communications. Our aim is to encourage scientists to publish their ex-perimental and theoretical results in as much detail as possible so that the results can be reproduced. Therefore, there is no restriction on the length of the papers. We are committed to drive Ceramics to a position in which it is recognized for its high-quality, cutting-edge research and scientific influence, and strongly encourage and invite your participation and manuscripts.
From IOP Publishing, our multidisciplinary journal Multifunctional Materials (MFM) serves an emerging field that now connects the materials science, physics, chemistry, bioscience and engineering communities, and translational multifunctional sciences. As a highly selective journal, it’s primary aim is to publish original research of the highest quality, including fundamental concepts to integrate multiple functions, characterisation of functions, novel applications and manufacturing techniques, with the expectation for lasting scientific and technological impact. Discover more about our experienced top-level editorial board, and high-quality online production today. https://iopscience.iop.org/journal/2399-7532
Founded in 2005, Specanalítica is one of the leading companies in the Portuguese analytical market supported by a motivated and highly qualified team.
Focused on the Commercialization of internationally renowned brands in the fields
Analytical Chemistry, Material and Life Sciences, customer support and after-sales services are our priorities! We have Accredited Training Certification since 2012 for our customers!
Our mission: work in a partnership with our customers offering specialized analytical solutions to meet their analytical needs, keeping leadership as one of the most respected customer partners in the Portuguese industrial, analytical and life science market!
Our ambition is to be recognized for the excellent product range we offer and for the technical support provided!
Free Media Partner
Coatings (ISSN 2079-6412) is an international peer-reviewed and open access journal for the rapid dissemination of the latest research findings in the science and engineering of coatings, thin and thick films, surfaces and interfaces. It publishes original research papers and brief communications that report on the latest finding of research together with review papers that systematize the remarkable points on the state of the art. Since its establishment, Coatings has experienced a constant growth and is now affirmed as a primary platform for the dissemination of research within the surface and interface science and engineering community. Coatings is covered by leading indexing services, including Science Citation Index Expanded (Web of Science), Scopus (Elseiver), Inspec (IET) and other relevant databases. The latest Impact Factor (IF) is 2.436 and the CiteScore is 2.40. We look forward to receiving your contributions! If you mention the conference ESB 2021 in your coverletter, we can offer a 200 CHF discount for your paper.